|
Volumn 147, Issue 3, 2003, Pages 78-
|
CE: What R.Ph.s should know about osteoporosis
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
'POSTURE';
ALENDRONIC ACID;
ANTACID AGENT;
ANTICONVULSIVE AGENT;
ANTIINFECTIVE AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
CALCITONIN;
CALCIUM;
CALCIUM CARBONATE;
CALCIUM PHOSPHATE;
CALTRATE D;
CITRATE CALCIUM;
CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;
CYCLOSPORIN;
DIURETIC AGENT;
ESTROGEN;
GLUCOCORTICOID;
HEPARIN;
PARATHYROID HORMONE[1-34];
PLACEBO;
RALOXIFENE;
RISEDRONIC ACID;
SALCATONIN;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
TETRACYCLINE;
THYROID HORMONE;
TOREMIFENE;
TURNS;
TURNS EX;
TURNS ULTRA;
UNCLASSIFIED DRUG;
VIACTIV;
VITAMIN D;
BLOOD PRESSURE;
BONE DENSITY;
BONE REMODELING;
BREAST TENDERNESS;
CALCIUM BLOOD LEVEL;
CALCIUM URINE LEVEL;
DIAGNOSTIC PROCEDURE;
DIET;
DRUG EFFECT;
EDEMA;
EXERCISE;
FOOD AND DRUG ADMINISTRATION;
FRACTURE;
GASTROINTESTINAL SYMPTOM;
HORMONE SUBSTITUTION;
HOT FLUSH;
HUMAN;
INCIDENCE;
MEDICAL EDUCATION;
MOOD CHANGE;
MUSCLE CRAMP;
NAUSEA;
ORTHOSTATIC HYPOTENSION;
OSTEOLYSIS;
OSTEOPOROSIS;
PATHOPHYSIOLOGY;
PHARMACY;
REVIEW;
RHINITIS;
RISK FACTOR;
SIDE EFFECT;
SKIN IRRITATION;
SWEATING;
THROMBUS;
WEIGHT GAIN;
|
EID: 14744286269
PISSN: 00126616
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (0)
|